Thrombin Market - Global Forecast 2026-2032

The current thrombin market is experiencing significant shifts, with executive leaders needing a streamlined view of clinical, commercial, and supply-chain trends to inform strategic decisions. This analysis delivers actionable direction for stakeholders navigating procurement, manufacturing, and clinical adoption of thrombin solutions in a rapidly evolving environment.

Market Snapshot

The Thrombin Market advanced from USD 728.68 million in 2025 to USD 780.92 million in 2026 and is forecast to reach USD 1.12 billion by 2032, demonstrating a CAGR of 6.42%. This sustained growth underscores increasing demand for advanced haemostatic agents across both mature and emerging regions, influenced by recombinant technology innovation, regulatory demands, and changing hospital procurement dynamics.

Scope & Segmentation

Product Types: Bovine thrombin, human thrombin, and recombinant thrombin distinguished by safety profiles, supply chains, and manufacturing needs.
Applications: Includes dental surgery, cardiac, general, neurosurgical, orthopedic, and trauma care, each with specific clinical requirements and adoption drivers.
End Users: Hospital systems, ambulatory surgery centers, and clinics, each with unique contracting and inventory management priorities.
Formulations: Gel, liquid, and lyophilized powder, each presenting distinct usability, storage, and workflow impacts.
Distribution Channels: Direct sales, distributor partnerships, hospital pharmacies, and online channels, influencing access and pricing transparency.
Regions: Americas, Europe Middle East & Africa, and Asia-Pacific reflecting varied regulatory, commercial, and infrastructure conditions.
Technologies: Emphasis on recombinant protein engineering, advanced formulation science, and traceability solutions.

Key Takeaways

Recombinant innovation is reducing immunogenicity risks, supporting safer and more consistent thrombin solutions that align with emerging clinician expectations.
Formulation advancements, particularly in gel, liquid, and powder forms, are supporting adoption in minimally invasive and specialized surgical procedures.
Regulatory tightening is prompting greater investments in post-market surveillance, pharmacovigilance, and labeling strategies among manufacturers.
Supply-chain resilience is increasingly critical, with localized production and vertical integration strategies mitigating logistics and regulatory exposure.
Segmented end-users require tailored approaches: hospitals demand comprehensive evidence and contracting, while ambulatory centers and clinics prioritize ease of use and cost control.
Distribution channel evolution introduces both new market access points and compliance challenges, necessitating strategic channel management and quality assurance.

Tariff Impact

Recent tariff shifts have intensified operational complexity and reshaped sourcing and manufacturing decisions. Increased landed costs for imported thrombin inputs have compelled providers to re-examine procurement contracts and accelerate interest in localized manufacturing. Recombinant manufacturing now provides flexibility in scaling production to reduce customs and logistics burdens. While larger hospital systems gain leverage in managing tariff exposure, smaller clinics face heightened price sensitivity and must adapt procurement approaches accordingly. Online channels offer alternative routes but can introduce additional quality and compliance concerns. Overall, tariffs have made adaptable supply-chain architecture and renegotiation strategies imperative.

Methodology & Data Sources

This report synthesizes evidence from structured interviews with specialists in cardiac, orthopedic, neurosurgical, general surgery, dental, and trauma disciplines, as well as procurement leaders from provider organizations. Supplementary insights were derived from regulatory filings, clinical trial data, and secondary industry documentation. Data were triangulated across clinician feedback, procurement trends, and supplier disclosures to ensure robust, scenario-based analysis and cross-regional validity.

Why This Report Matters

Equips executives with a clear, clinician-informed view of thrombin product positioning, segmentation, and market forces for confident decision-making.
Guides investment in recombinant and differentiated formulations, supply-chain flexibility, and regional strategies to optimize adoption and mitigate policy-driven risks.
Provides prioritized, actionable recommendations to help leaders balance clinical outcomes, cost efficiency, and long-term commercial success.

Conclusion

Aligning recombinant technology, innovative formulations, and supply-chain resilience is essential for securing lasting clinical adoption and operational stability. This report empowers senior leaders to navigate regulatory complexity, supplier dynamics, and evolving end-user needs in the thrombin market.

1. Preface

1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders

2. Research Methodology

2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations

3. Executive Summary

3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap

4. Market Overview

4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy

5. Market Insights

5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025

8. Thrombin Market, by Product Type

8.1. Bovine Thrombin
8.2. Human Thrombin
8.3. Recombinant Thrombin

9. Thrombin Market, by Formulation

9.1. Gel
9.2. Liquid Form
9.3. Lyophilized Powder

10. Thrombin Market, by Application

10.1. Dental Surgery
10.2. Surgical Hemostasis
10.2.1. Cardiac Surgery
10.2.2. General Surgery
10.2.3. Neurosurgery
10.2.4. Orthopedic Surgery
10.3. Trauma Care

11. Thrombin Market, by End User

11.1. Ambulatory Surgery Centers
11.2. Clinics
11.3. Hospitals

12. Thrombin Market, by Distribution Channel

12.1. Direct Sales
12.2. Distributors
12.3. Hospital Pharmacies
12.4. Online Sales

13. Thrombin Market, by Region

13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific

14. Thrombin Market, by Group

14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO

15. Thrombin Market, by Country

15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea

16. United States Thrombin Market
17. China Thrombin Market

18. Competitive Landscape

18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Baxter International Inc.
18.6. Becton, Dickinson and Company
18.7. Bio-Products Laboratory Ltd.
18.8. Biogen Inc.
18.9. China Biologic Products Holdings, Inc.
18.10. CSL Limited
18.11. Ferring B.V.
18.12. GE Healthcare
18.13. Green Cross Corporation
18.14. Grifols, S.A.
18.15. Haematologic Technologies, Inc.
18.16. Haemonetics Corporation
18.17. Hualan Biological Engineering, Inc.
18.18. Johnson & Johnson
18.19. Kedrion Biopharma, Inc.
18.20. King Pharmaceuticals, Inc.
18.21. LFB S.A.
18.22. Merck KGaA
18.23. Omrix Biopharmaceuticals, Ltd.
18.24. Pfizer Inc.
18.25. ProFibrix B.V.
18.26. Takeda Pharmaceutical Company Limited
18.27. Valiant Co., Ltd.
18.28. ZymoGenetics, Inc.

List of Figures

FIGURE 1. GLOBAL THROMBIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL THROMBIN MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL THROMBIN MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL THROMBIN MARKET SIZE, BY FORMULATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL THROMBIN MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL THROMBIN MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL THROMBIN MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES THROMBIN MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA THROMBIN MARKET SIZE, 2018-2032 (USD MILLION)

List of Tables

TABLE 1. GLOBAL THROMBIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL THROMBIN MARKET SIZE, BY BOVINE THROMBIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL THROMBIN MARKET SIZE, BY HUMAN THROMBIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL THROMBIN MARKET SIZE, BY HUMAN THROMBIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL THROMBIN MARKET SIZE, BY HUMAN THROMBIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY REGION, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY GROUP, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL THROMBIN MARKET SIZE, BY RECOMBINANT THROMBIN, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL THROMBIN MARKET SIZE, BY GEL, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL THROMBIN MARKET SIZE, BY GEL, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL THROMBIN MARKET SIZE, BY GEL, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL THROMBIN MARKET SIZE, BY LIQUID FORM, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL THROMBIN MARKET SIZE, BY LIQUID FORM, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL THROMBIN MARKET SIZE, BY LIQUID FORM, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL THROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL THROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL THROMBIN MARKET SIZE, BY LYOPHILIZED POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL THROMBIN MARKET SIZE, BY DENTAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL THROMBIN MARKET SIZE, BY DENTAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL THROMBIN MARKET SIZE, BY DENTAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL THROMBIN MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL THROMBIN MARKET SIZE, BY CARDIAC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL THROMBIN MARKET SIZE, BY CARDIAC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL THROMBIN MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL THROMBIN MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL THROMBIN MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL THROMBIN MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL THROMBIN MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL THROMBIN MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL THROMBIN MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL THROMBIN MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL THROMBIN MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL THROMBIN MARKET SIZE, BY TRAUMA CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL THROMBIN MARKET SIZE, BY TRAUMA CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL THROMBIN MARKET SIZE, BY TRAUMA CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL THROMBIN MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL THROMBIN MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL THROMBIN MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL THROMBIN MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL THROMBIN MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL THROMBIN MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL THROMBIN MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL THROMBIN MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL THROMBIN MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL THROMBIN MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL THROMBIN MARKET SIZE, BY DISTRIBUTORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL THROMBIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL THROMBIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL THROMBIN MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL THROMBIN MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL THROMBIN MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL THROMBIN MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL THROMBIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 69. AMERICAS THROMBIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 70. AMERICAS THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 71. AMERICAS THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 72. AMERICAS THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 73. AMERICAS THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 74. AMERICAS THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 75. AMERICAS THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 76. NORTH AMERICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 77. NORTH AMERICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 78. NORTH AMERICA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 79. NORTH AMERICA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 80. NORTH AMERICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 81. NORTH AMERICA THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 82. NORTH AMERICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 83. LATIN AMERICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 84. LATIN AMERICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 85. LATIN AMERICA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 86. LATIN AMERICA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 87. LATIN AMERICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 88. LATIN AMERICA THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 89. LATIN AMERICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 97. EUROPE THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 98. EUROPE THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 99. EUROPE THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 100. EUROPE THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 101. EUROPE THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 102. EUROPE THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 103. EUROPE THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 104. MIDDLE EAST THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 105. MIDDLE EAST THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 106. MIDDLE EAST THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 107. MIDDLE EAST THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 108. MIDDLE EAST THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 109. MIDDLE EAST THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 110. MIDDLE EAST THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 111. AFRICA THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 112. AFRICA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 113. AFRICA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 114. AFRICA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. AFRICA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 116. AFRICA THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 117. AFRICA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 125. GLOBAL THROMBIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 126. ASEAN THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 127. ASEAN THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 128. ASEAN THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 129. ASEAN THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 130. ASEAN THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 131. ASEAN THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 132. ASEAN THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 133. GCC THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 134. GCC THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 135. GCC THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 136. GCC THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 137. GCC THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 138. GCC THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 139. GCC THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 140. EUROPEAN UNION THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 141. EUROPEAN UNION THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 142. EUROPEAN UNION THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 143. EUROPEAN UNION THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 144. EUROPEAN UNION THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 145. EUROPEAN UNION THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 146. EUROPEAN UNION THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 147. BRICS THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 148. BRICS THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 149. BRICS THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 150. BRICS THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. BRICS THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 152. BRICS THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 153. BRICS THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 154. G7 THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 155. G7 THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 156. G7 THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 157. G7 THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 158. G7 THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 159. G7 THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 160. G7 THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 161. NATO THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 162. NATO THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 163. NATO THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 164. NATO THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 165. NATO THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 166. NATO THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 167. NATO THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 168. GLOBAL THROMBIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 169. UNITED STATES THROMBIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 170. UNITED STATES THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 171. UNITED STATES THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 172. UNITED STATES THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 173. UNITED STATES THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 174. UNITED STATES THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 175. UNITED STATES THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
TABLE 176. CHINA THROMBIN MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 177. CHINA THROMBIN MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
TABLE 178. CHINA THROMBIN MARKET SIZE, BY FORMULATION, 2018-2032 (USD MILLION)
TABLE 179. CHINA THROMBIN MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 180. CHINA THROMBIN MARKET SIZE, BY SURGICAL HEMOSTASIS, 2018-2032 (USD MILLION)
TABLE 181. CHINA THROMBIN MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 182. CHINA THROMBIN MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Thrombin market report include:

Baxter International Inc.
Becton, Dickinson and Company
Bio-Products Laboratory Ltd.
Biogen Inc.
China Biologic Products Holdings, Inc.
CSL Limited
Ferring B.V.
GE Healthcare
Green Cross Corporation
Grifols, S.A.
Haematologic Technologies, Inc.
Haemonetics Corporation
Hualan Biological Engineering, Inc.
Johnson & Johnson
Kedrion Biopharma, Inc.
King Pharmaceuticals, Inc.
LFB S.A.
Merck KGaA
Omrix Biopharmaceuticals, Ltd.
Pfizer Inc.
ProFibrix B.V.
Takeda Pharmaceutical Company Limited
Valiant Co., Ltd.
ZymoGenetics, Inc.

Table Information

Report Attribute	Details
No. of Pages	197
Published	January 2026
Forecast Period	2026 - 2032
Estimated Market Value ( USD ) in 2026	$ 780.92 Million
Forecasted Market Value ( USD ) by 2032	$ 1120 Million
Compound Annual Growth Rate	6.4%
Regions Covered	Global
No. of Companies Mentioned	25

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3511EUR$3,939USD£3,045GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€3787EUR$4,249USD£3,285GBP
SITE LICENSE PDF, Excel and Online Access	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5133EUR$5,759USD£4,452GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6212EUR$6,969USD£5,387GBP

Market Snapshot

Scope & Segmentation

Key Takeaways

Tariff Impact

Methodology & Data Sources

Why This Report Matters

Conclusion

Table of Contents

Companies Mentioned

Table Information

Related Topics

Related Reports

Thrombin - Global Strategic Business Report

Thrombin Market Report and Forecast 2025-2034

Thrombin-Jmi, Thrombocoll Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

Direct Thrombin Inhibitors Market - Global Forecast 2025-2030

Factor IIa (Thrombin) Inhibitor - Pipeline Insight, 2025